NM_001256789.3:c.1933A>G

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2

The NM_001256789.3(CACNA1F):​c.1933A>G​(p.Ile645Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000583 in 1,200,838 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I645F) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 21)
Exomes 𝑓: 0.0000055 ( 0 hom. 3 hem. )

Consequence

CACNA1F
NM_001256789.3 missense

Scores

7
8
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.96

Publications

0 publications found
Variant links:
Genes affected
CACNA1F (HGNC:1393): (calcium voltage-gated channel subunit alpha1 F) This gene encodes a multipass transmembrane protein that functions as an alpha-1 subunit of the voltage-dependent calcium channel, which mediates the influx of calcium ions into the cell. The encoded protein forms a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Mutations in this gene can cause X-linked eye disorders, including congenital stationary night blindness type 2A, cone-rod dystropy, and Aland Island eye disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Aug 2013]
CACNA1F Gene-Disease associations (from GenCC):
  • Aland island eye disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • inherited retinal dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness 2A
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • X-linked cone-rod dystrophy 3
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BS2
High AC in GnomAdExome4 at 6 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1FNM_001256789.3 linkc.1933A>G p.Ile645Val missense_variant Exon 15 of 48 ENST00000323022.10 NP_001243718.1 O60840-2
CACNA1FNM_005183.4 linkc.1966A>G p.Ile656Val missense_variant Exon 15 of 48 NP_005174.2 O60840-1
CACNA1FNM_001256790.3 linkc.1771A>G p.Ile591Val missense_variant Exon 15 of 48 NP_001243719.1 O60840-4
CACNA1FXM_011543983.3 linkc.1771A>G p.Ile591Val missense_variant Exon 15 of 47 XP_011542285.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1FENST00000323022.10 linkc.1933A>G p.Ile645Val missense_variant Exon 15 of 48 1 NM_001256789.3 ENSP00000321618.6 O60840-2
CACNA1FENST00000376265.2 linkc.1966A>G p.Ile656Val missense_variant Exon 15 of 48 1 ENSP00000365441.2 O60840-1
CACNA1FENST00000376251.5 linkc.1771A>G p.Ile591Val missense_variant Exon 15 of 48 1 ENSP00000365427.1 O60840-4
CACNA1FENST00000480889.1 linkn.63A>G non_coding_transcript_exon_variant Exon 1 of 4 5

Frequencies

GnomAD3 genomes
AF:
0.00000904
AC:
1
AN:
110614
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.0000330
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000550
AC:
6
AN:
1090224
Hom.:
0
Cov.:
30
AF XY:
0.00000841
AC XY:
3
AN XY:
356530
show subpopulations
African (AFR)
AF:
0.0000380
AC:
1
AN:
26317
American (AMR)
AF:
0.00
AC:
0
AN:
34408
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19239
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30107
South Asian (SAS)
AF:
0.0000190
AC:
1
AN:
52686
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40092
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4101
European-Non Finnish (NFE)
AF:
0.00000478
AC:
4
AN:
837418
Other (OTH)
AF:
0.00
AC:
0
AN:
45856
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000904
AC:
1
AN:
110614
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
32854
show subpopulations
African (AFR)
AF:
0.0000330
AC:
1
AN:
30334
American (AMR)
AF:
0.00
AC:
0
AN:
10406
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2639
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3502
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2595
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5869
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52868
Other (OTH)
AF:
0.00
AC:
0
AN:
1484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jul 19, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 1054585). This variant has not been reported in the literature in individuals affected with CACNA1F-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 656 of the CACNA1F protein (p.Ile656Val). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.38
BayesDel_addAF
Pathogenic
0.26
D
BayesDel_noAF
Pathogenic
0.14
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.62
.;.;D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D;D;D
M_CAP
Pathogenic
0.87
D
MetaRNN
Uncertain
0.62
D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.2
.;.;M
PhyloP100
8.0
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.91
N;N;N
REVEL
Pathogenic
0.75
Sift
Uncertain
0.023
D;D;D
Sift4G
Uncertain
0.024
D;D;D
Polyphen
0.90
.;.;P
Vest4
0.44
MutPred
0.71
.;.;Loss of catalytic residue at L661 (P = 0.0747);
MVP
0.94
MPC
0.60
ClinPred
0.97
D
GERP RS
4.0
Varity_R
0.48
gMVP
0.86
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1344295491; hg19: chrX-49079540; API